Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

Here at the American Association for Cancer Research (AACR) meeting, Day 2 brought us a packed Plenary session in a huge hangar of a hall. It was at this point I realised this is now a much much bigger meeting than I remember in the past, with an enormous variety of sessions and symposia, many running concurrently.

AACR are doing a great job posting full podcasts and webcasts of the event for those who couldn’t attend. The Varmus podcast is now live, for example. There is also one with Dr Ervin Epstein on the Hedgehog inhibitor I mentioned in basal cell nevus syndrome.

The full list of currently live podcasts have been posted by AACR. Do check it out as they post new content daily.

In case you are wondering, there is also a short video of the Day 1 highlights on Sat for those of you who are interested.

I won’t be posting a video tomorrow morning due to a commitment tonight to attend the inaugural #AACR tweetup organised by Angela Alexander (@flutesUD), a cancer researcher at MD Anderson whose work is focused on ATM. She is an up and coming scientist who recently won the PNAS Cozzarelli Prize for the top paper in biological sciences. If anyone is around at AACR and using Twitter, you are most welcome to just the motley crew at the Tweetup at the Peabody fountain bar around 6-8.30pm. A mixed group of scientists, patient advocates, clinicians, bloggers and biotech people are expected!

One Response to “Highlights of AACR – Day 2”

Comments are closed.

error: Content is protected !!